ClinicalTrials.Veeva

Menu

Treatment of Breast Lift/Reduction Scars

Sciton logo

Sciton

Status

Withdrawn

Conditions

Scars

Treatments

Other: Non-treatment side (Control)
Device: 2940nm and BBL treatment

Study type

Interventional

Funder types

Industry

Identifiers

NCT05123508
SCARCIP001

Details and patient eligibility

About

Laser and light treatment for surgical scars following breast lifts/reductions

Full description

The purpose of the study is to demonstrate effectiveness of laser and light therapy for the treatment of surgical scars following breast lifts/reductions.

Sex

Female

Ages

25 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Healthy female subjects between 25 to 60 years of age inclusive
  2. Fitzpatrick skin type I-IV
  3. Subjects with post-surgical breast lift/reduction scar
  4. A maximum of 8-10 weeks since surgery
  5. Healed surgery wound in the treatment area
  6. Willing to have photographs taken of the treatment area
  7. Can read, understand and sign informed consent form (English only)
  8. Has indicated willingness to participate in the study by signing an informed consent form
  9. Agrees to adhere to the treatment and follow-up schedule and post treatment care instructions

Exclusion criteria

  1. Fitzpatrick skin type V-VI
  2. Breast reconstruction with radiation treatment
  3. Is pregnant and/or lactating
  4. Has tattoos, dysplastic nevi in the treatment area
  5. History or current photosensitivity
  6. History or current use of medication with photosensitizing properties within past 6 months
  7. History or current of chronic reoccurring skin disease or disorder affecting treatment area
  8. History or current cancer of any type
  9. Has hormonal disorder
  10. Has signs of actinic bronzing
  11. Has open lacerations, and abrasions on the treatment area
  12. History of keloid formation, or hypertrophic scar formation, or poor wound healing
  13. History of bleeding disorder, or is currently taking anticoagulation medications
  14. Has significant concurrent illnesses (controlled or uncontrolled), such as diabetes, lupus, epilepsy, or cardiac disorders, which might be aggravated as a result of treatment
  15. Has participated in any clinical trial involving an investigational drug, device or cosmetic product or procedure within the past 30 days
  16. The investigator feels that for any reason the subject is not eligible to participate in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Treatment Arm
Experimental group
Description:
2940nm laser and BBL treatment
Treatment:
Device: 2940nm and BBL treatment
Control Arm
Experimental group
Description:
One side of the treatment area will act as a control. No treatment on the control side.
Treatment:
Other: Non-treatment side (Control)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems